Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objectives</h3><p>Parkinson's Disease (PD) is a neurodegenerative process affecting motor function that involves an inflammatory response and B vitamins deficiencies. The aim of this study was to evaluate the effect of B-group vitamin producing and immunomodulatory lactic acid bacteria (LAB) in a murine model of PD.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>The effect of <em>Lactobacillus plantarum</em> CRL 2130 (a riboflavin producer), <em>Streptococcus thermophilus</em> CRL 807 (an immunomodulatory strain) and <em>Streptococcus thermophilus</em> CRL 808 (a folate producer) were evaluated individually and as a mixture in mice injected with 1-methyl-4-fenil-1,2,3,6-tetrahidropiridina (MPTP). Motor capacity, tyrosine hydrolase (TH) in brain and cytokine concentrations in serum and in brain tissues were evaluated in MPTP treated mice after bacterial supplementation. <em>Results</em>: Mice receiving the selected LAB showed significantly improved motor skills compared to those that did not receive bacterial supplementation. When given the mixture of all 3 strains together, animals had higher brain TH+ cell counts, decreased the inflammatory cytokines IL-6 and TNF-α in serum and increased the anti-inflammatory cytokine IL-10 in serum and brain tissues compared to animals that did not receive LAB supplementation.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>The results showed the potential of a selected LAB mixture to improve motor behavior and neuroinflammation in PD. This probiotic mixture could be used as an adjunct treatment in the control of PD.</p>

Neuroprotective effects associated with immune modulation by selected lactic acid bacteria in a Parkinson's disease model